PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+40.67%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$415M
AUM Growth
+$415M
(+6.3%)
Cap. Flow
-$37.8M
Cap. Flow
% of AUM
-9.11%
Top 10 Holdings %
Top 10 Hldgs %
39.8%
Holding
104
New
20
Increased
36
Reduced
26
Closed
21
Top Buys
| 1 |
United Therapeutics
UTHR
|
$12.5M |
| 2 |
Amgen
AMGN
|
$11.2M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$4.08M |
| 4 |
Danaher
DHR
|
$3.89M |
| 5 |
EDAP
EDAP TMS
EDAP
|
$3.73M |
Top Sells
| 1 |
Vericel Corp
VCEL
|
$16.2M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$9.87M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$9.41M |
| 4 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
$9.02M |
| 5 |
Schrodinger
SDGR
|
$8.82M |
Sector Composition
| 1 | Healthcare | 95.8% |
| 2 | Technology | 1.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Aclaris Therapeutics
ACRS
$209M
| $43.1M | 10% | 1,709,136 -166,200 | -9% | -$4.19M |
|
|
2
Danaher
DHR
$147B
| $14.6M | 3.39% | 64,985 +17,298 | +36% | +$3.89M |
|
3
Charles River Laboratories
CRL
$8.04B
| $14.5M | 3.36% | 50,000 +10,334 | +26% | +$3M |
|
4
Natera
NTRA
$23.1B
| $14.2M | 3.3% | 139,893 +19,026 | +16% | +$1.93M |
|
5
Humana
HUM
$36.5B
| $13.8M | 3.21% | 33,000 +8,192 | +33% | +$3.43M |
|
|
ICAD
6
DELISTED
iCAD Inc
ICAD
| $13.8M | 3.19% | 648,131 +105,529 | +19% | +$2.24M |
|
7
DexCom
DXCM
$29.5B
| $13.6M | 3.15% | 37,718 -3,810 | -9% | -$1.37M |
|
8
IQVIA
IQV
$32.4B
| $12.8M | 2.96% | 66,048 +7,824 | +13% | +$1.51M |
|
|
9
United Therapeutics
UTHR
$13.8B
| $12.5M | 2.91% | +74,874 | New | +$12.5M |
|
|
CDMO
10
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $12.3M | 2.86% | 675,000 -74,511 | -10% | -$1.36M |
|
|
11
Amgen
AMGN
$155B
| $11.2M | 2.6% | +45,059 | New | +$11.2M |
|
|
12
Alnylam Pharmaceuticals
ALNY
$58.5B
| $9.18M | 2.13% | 65,043 +28,882 | +80% | +$4.08M |
|
13
Arcus Biosciences
RCUS
$1.13B
| $8.87M | 2.06% | 315,882 +84,124 | +36% | +$2.36M |
|
|
XLRN
14
DELISTED
Acceleron Pharma Inc.
XLRN
| $8.51M | 1.98% | 62,780 +10,322 | +20% | +$1.4M |
|
|
CTLT
15
DELISTED
CATALENT, INC.
CTLT
| $8.38M | 1.94% | 79,526 -4,593 | -5% | -$484K |
|
16
Insulet
PODD
$23.9B
| $8.13M | 1.89% | 31,169 +582 | +2% | +$152K |
|
|
ITMR
17
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $8.06M | 1.87% | 336,429 +54,102 | +19% | +$1.3M |
|
|
DRNA
18
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $7.76M | 1.8% | 303,268 -28,245 | -9% | -$722K |
|
19
Avantor
AVTR
$9.18B
| $7.3M | 1.69% | 252,163 +101,291 | +67% | +$2.93M |
|
20
Xenon Pharmaceuticals
XENE
$2.98B
| $6.7M | 1.56% | 374,395 +12,706 | +4% | +$227K |
|
|
ONCT
21
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $6.48M | 1.5% | 778,785 +402,006 | +107% | +$3.34M |
|
22
Immunic
IMUX
$80.9M
| $6.4M | 1.48% | 401,218 +34,527 | +9% | +$550K |
|
|
HZNP
23
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $6.3M | 1.46% | 68,430 -107,282 | -61% | -$9.87M |
|
|
24
Vericel Corp
VCEL
$1.83B
| $6.11M | 1.42% | 110,000 -290,743 | -73% | -$16.2M |
|
25
InfuSystem Holdings
INFU
$220M
| $5.68M | 1.32% | 278,833 +37,322 | +15% | +$760K |
|